|
ZNF674 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.972080E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.867200E-01 |
| Normal-vs-Stage2 |
9.982600E-01 |
| Normal-vs-Stage3 |
2.339900E-03 |
| Normal-vs-Stage4 |
3.57349999999812E-05 |
| Stage1-vs-Stage2 |
7.287400E-01 |
| Stage1-vs-Stage3 |
1.929830E-02 |
| Stage1-vs-Stage4 |
5.564500E-04 |
| Stage2-vs-Stage3 |
1.467560E-01 |
| Stage2-vs-Stage4 |
6.736300E-02 |
| Stage3-vs-Stage4 |
4.905200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.686000E-02 |
| Normal-vs-AfricanAmerican |
1.905560E-02 |
| Normal-vs-Asian |
9.655700E-02 |
| Caucasian-vs-AfricanAmerican |
3.081800E-01 |
| Caucasian-vs-Asian |
4.042400E-02 |
| AfricanAmerican-vs-Asian |
9.155100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.932200E-02 |
| Normal-vs-Female |
1.564010E-02 |
| Male-vs-Female |
6.263600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.167600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.556400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.423300E-03 |
| Normal-vs-Age(81-100Yrs) |
6.976000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.858300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.204400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.825400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.845900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.788000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.575400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.313010E-01 |
| Normal-vs-Grade 2 |
5.336000E-01 |
| Normal-vs-Grade 3 |
1.163580E-02 |
| Normal-vs-Grade 4 |
1.43960000031917E-07 |
| Grade 1-vs-Grade 2 |
1.130980E-01 |
| Grade 1-vs-Grade 3 |
1.547680E-02 |
| Grade 1-vs-Grade 4 |
1.604920E-04 |
| Grade 2-vs-Grade 3 |
8.155600E-02 |
| Grade 2-vs-Grade 4 |
1.61561999999504E-05 |
| Grade 3-vs-Grade 4 |
4.138300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.535600E-01 |
| Normal-vs-ccB subtype |
1.970580E-01 |
| ccA subtype-vs-ccB subtype |
2.278000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.105600E-02 |
| Normal-vs-N1 |
4.036800E-04 |
| N0-vs-N1 |
1.669760E-01 |
|
|
